173 - Viral Infections in Children

Friday, October 18, 2024

3:15 PM – 4:30 PM US PT

Location: 408 B

All relevant financial relationships have been mitigated.

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit
CNE Credits: Maximum of 1.25 hours of ANCC Credit
ACPE Credits: ACPE 1.25 knowledge-based contact hours of pharmacy CE
ACPE Number: JA0007082-9999-24-002-L01-P
PACE Credits: Maximum of 1 of PACE contact hours
CE Broker: Maximum of 1 CE broker credit hours

Moderator(s)

Christine Johnston, MD, MPH (she/her/hers)

Associate Professor
Medicine
University of Washington
Seattle, WA, United States
EM

Elizabeth Moulton, MD, PhD

Assistant Professor of Pediatrics
Pediatric Infectious Disease and Transplant
Baylor College of Medicine and Texas Children's Hospital
Houston, TX, United States

Faculty(s)

IJ Anosike, MD, MPH (she/her/hers)

Assistant Professor of Pediatrics
Montefiore Medical Center/ Children’s Hospital at Montefiore
Bronx, NY, United States
Hai Nguyen-Tran, MD (she/her/hers)

Assistant Professor of Pediatrics, Section of Infectious Diseases
University of Colorado/Children's Hospital Colorado
Aurora, CO, United States
HK

Hannah Kirking, MD

Outbreak Response and Community Transmission Team Lead
Coronavirus and Other Respiratory Viruses Division, National Center for Immunization and Respiratory Diseases, CDC
Atlanta, GA, United States

Disclosure(s):

Christine Johnston, MD, MPH: Assembly Bioscience: Advisor/Consultant (Ongoing); Gilead Biosciences: Grant/Research Support (Terminated, December 31, 2022); GSK: Advisor/Consultant (Ongoing), Grant/Research Support (Ongoing); Moderna, Inc.: Grant/Research Support (Ongoing); Pfizer, Inc.: Advisor/Consultant (Ongoing)

Elizabeth A. Moulton, MD, PhD: Pfizer, Inc.: Grant/Research Support (Ongoing)

IJ Anosike, MD, MPH: No financial relationships to disclose

Hai D. Nguyen-Tran, MD: No financial relationships to disclose

Hannah L. Kirking, MD: No financial relationships to disclose

Learning Objectives:

At the conclusion of this session, participants will be able to:

describe the epidemiology and treatment of covid-19 in children;
diagnose syndromes associated with pediatric enteroviruses;
identify adenovirus surveillance systems and recent adenovirus outbreaks.

Presentations:

3:15 PM – 3:40 PM US PT

COVID-19 in Children: Navigating the Current Landscape Amid Vaccine Hesitancy
Speaker: IJ Anosike, MD, MPH (she/her/hers) – Montefiore Medical Center/ Children’s Hospital at Montefiore
3:40 PM – 4:05 PM US PT

Pediatric Enteroviruses: Infections from Head to Toe
Speaker: Hai D. Nguyen-Tran, MD (she/her/hers) – University of Colorado/Children's Hospital Colorado
4:05 PM – 4:30 PM US PT

Adenovirus Infections within the United States: Surveillance and Outbreaks
Speaker: Hannah L. Kirking, MD – Coronavirus and Other Respiratory Viruses Division, National Center for Immunization and Respiratory Diseases, CDC